Rifampin resistance among individuals with extrapulmonary tuberculosis: 4 years of experience from a reference laboratory.

Baghbanbashi, S; Mousavi, S Mohammad J; Dabiri, H; Hakemi-Vala, M; Goudarzi, H; Hamzehloo, G; Amini, S; Nasiri, M J

Baghbanbashi, S; Mousavi, S Mohammad J; Dabiri, H; Hakemi-Vala, M; Goudarzi, H; Hamzehloo, G; Amini, S; Nasiri, M J.

Afiliación

Baghbanbashi S; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mousavi SMJ; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Dabiri H; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hakemi-Vala M; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Goudarzi H; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamzehloo G; Regional Tuberculosis Reference Laboratory, Tehran University of Medical Sciences, Tehran, Iran.
Amini S; Regional Tuberculosis Reference Laboratory, Tehran University of Medical Sciences, Tehran, Iran.
Nasiri MJ; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

New Microbes New Infect ; 40: 100841, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33664961

Palabras clave

Drug resistance; Iran; Mycobacterium tuberculosis; extrapulmonary tuberculosis; rifampin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: New Microbes New Infect Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google